Effects of maternal first trimester thyroid stimulant hormone levels on birth weights of fetuses born at term. Perinatal Journal 2015;23(2):79–83
- Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, Kahramanmaraş
- Tatvan Devlet Hastanesi Kadın Hastalıkları ve Doğum Kliniği, Bitlis
- Patnos Devlet Hastanesi Kadın Hastalıkları ve Doğum Kliniği, Ağrı
Murat Bakacak, Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, Kahramanmaraş, [email protected]
Manuscript Received: November 25, 2014
Manuscript Accepted: March 20, 2015
Earlyview Date: April 03, 2015
Conflicts of Interest
Conflicts of Interest: No conflicts declared.
We aimed to investigation the relationship between first trimester maternal thyroid stimulant hormone (TSH) levels and fetal birth weight in pregnants with TSH results within normal ranges.
A total of 193 patients meeting study criteria were separated into two groups according to their TSH levels found at first trimester as those between 0.4 and 2.5 mU/L, and those between 2.5 and 4.2 mU/L. There were 162 patients in the first group (Group 1) with TSH level between 0.4 and 2.5 mU/L, and 31 patients in the second group (Group 2) with TSH level between 2.5 and 4.2 mU/L. Birth weights were also categorized under three groups which were <2500 g, 2500–3500 g and >3500 g. These three fetal weight groups and two TSH groups established according to their first trimester measurements were compared.
When both groups were compared in terms of demographic data and fetal weight, there was no significant difference between two groups in terms of the parameters analyzed. In both TSH groups, distribution percentages of the patients were found statistically similar according to fetal birth weights.
We found that normal TSH levels have no effect on fetal birth weight and that a further examination may not be required in terms of thyroid functions when TSH level is found within normal ranges at first trimester in terms of affecting fetal weight.
Thyroid stimulant hormone, fetal birth weight, hypothyroidism.
During pregnancy, significant changes occur in thyroid physiology and function. One of the most significant reasons is human chorionic gonadotrophin (hCG) within glycoprotein structure produced by placenta at first trimester. hCG increasing in serum is attached to TSH receptor in the thyroid cell membrane and causes T4 and T3 secretion to increase. Due to this thyrotropic activity of hCG, lower TSH levels are found in the first trimester of pregnancy compared to non-pregnant women. Despite some differences between different resources and clinics, normal reference range of TSH is generally accepted between 2.5 and 97.5 percentiles and given between 0.03 and 4.04 MU/L.
Severe and sub-clinic hypothyroidism is the most frequent endocrine disorder, and its prevalence is reported as 2–5%. Hypothyroidism is reported with lower rate, and its prevalence is between 0.1% and 0.04%.
The incidence of thyroid dysfunction increased in the last decade and it was reported that this was associated with poor maternal and fetal outcomes.[1,6,7] In different studies, there is a consensus that maternal thyroid hormones are effective on the fetal development.[8,9–12] It is considered that severe maternal thyroid dysfunctions secondary to the suboptimal transplacental transition of maternal thyroid hormone are associated with low birth weights.
This brought up the discussion for scanning maternal thyroid hormones during pregnancy. There are different opinions on this matter.[14,15] Although it is clear that certain maternal and fetal thyroid dysfunctions are associated with low birth weight, the effects of thyroid function tests within normal ranges on fetal development is still unclear. Therefore, we aimed in this study to investigate if there is any relationship between first trimester maternal TSH level and fetal birth weight in pregnant women who have no severe pregestational thyroid dysfunction, do not have any treatment for any thyroid dysfunction during pregnancy and have serum TSH results within normal ranges.
The patients who referred to our clinic and had their all follow-ups and deliveries in our clinic between January 2013 and January 2014 were included in our retrospective study. Those with multiple pregnancies, develop fetal preeclampsia and gestational diabetes during pregnancy and gave birth before 37 weeks of gestation were excluded from the study. In our study, we included both vaginal and cesarean deliveries. The deliveries of all our patients who had elective cesarean were done between 39 and 40 weeks of gestation.
The data of 193 patients, who met all these criteria, had no thyroid dysfunction history and found to have TSH values within normal ranges in the first examination were included in the analysis. All data of the patients were obtained from electronic medical record system and patient file archives of the hospital.
In our clinic, maternal TSH levels are checked as a routine procedure in the first examination of patient. If abnormal values are found, free T3 and free T4 hormones are also checked, and patients are consulted with endocrinology department, if required. TSH values between 0.4 and 4.2 mU/L are considered normal in our clinic.
A total of 193 patients meeting study criteria were separated into two groups according to their TSH levels found at first trimester as those between 0.4 and 2.5 mU/L, and those between 2.5 and 4.2 mU/L. The cases were separated into three groups according to the fetal birth weight (<2500 g, 2500–3500 g and >3500 g), and they were compared according to their TSH levels as above.
The approval of Clinical Research Ethics Committee, Faculty of Medicine, Kahramanmaraş Sütçü İmam University was obtained for our study.
Statistical Package for the Social Sciences (SPSS) version 21 (SPSS Inc., Chicago, IL, USA) was used for the analysis of the data. Parametric methods were used for the analysis of variables with normal distribution and non-parametric methods were used for the analysis of variables without normal distribution. For the comparison of demographic data between groups, Independent-Samples T test and Mann-Whitney U (Exact) test were used, and mean ± SD (standard deviation) was found by median ± IQR (Interquartile Range). In the comparison of the groups in terms of TSH and birth weight, Pearson Chi-Square Test (Exact), Fisher Exact Test (Exact) and Linear-by-Linear Association Test were used. Categorical data were expressed as n (number) and percentage (%). The data were analyzed via 95% confidence interval, and p value less than 0.05 was considered significant.
The patients included in the study were separated into two different groups according to their TSH levels. There were 162 patients in the first group (Group 1) with TSH level between 0.4 and 2.5 mU/L, and 31 patients in the second group (Group 2) with TSH level between 2.5 and 4.2 mU/L.
The groups were compared in terms of age, gravida, parity, week of gestation, fetal birth weight and maternal hemoglobin (Hb) level, and no significant difference was found in terms of these parameters (Table 1). Since the patients who were at 42 weeks of gestation according to their last menstrual periods were delivered vaginally or by cesarean section, we had no pregnancy older than 42 weeks.
Later, the cases were distributed into three different groups according to their fetal birth weights (<2500 g, 2500–3500 g and >3500 g). The patients in these three groups were compared according to their TSH levels. In both TSH groups, distribution percentages of the patients were found similar according to fetal birth weights and no significant difference was observed (p=1) (Table 2).
Maternal thyroid dysfunctions and especially hypothyroidism and autoimmune problems affect gestational outcomes and fetal development negatively. However, no program is implemented for screening women in reproductive period in terms of thyroid functions. There is still no consensus on this matter.
While there are some differences among clinics, upper limit of TSH is 2.5 mU/L in the first trimester and 3 mU/L in the second trimester. In our study, TSH values between 0.4 and 4.2 mU/L in our clinic were considered normal.
In our study, we investigated the effects of TSH values being under or above 2.5 mU/L on gestational outcomes and birth weight in asymptomatic patients with TSH values within normal ranges and had no treatment for thyroid disorders. We found that maternal TSH levels did not affect fetal birth weight as long as they are within normal ranges.
Thyroid hormone concentration is one of the most effective biochemical markers to have a healthy fetal development. On the other hand, it has been shown in animal studies that thyroid hormones may have a direct role in fetal development and there may be abnormal skeletal development in those with thyroid hormone deficiency.[20,21]
The relationship between maternal thyroid dysfunction during pregnancy and birth weight was investigated in a series of studies.[8–10] In normal pregnancies, indirect effects of thyroid hormones on fetal growth were shown in previous studies as the low birth weight in babies of mothers with iodine deficiency in their diets compared to the babies of mothers who have sufficient iodine in their diets.
Most of the studies performed on thyroid dysfunctions during pregnancy were interested in the effects of sub-clinical or clinical hypothyroidism on gestational outcomes. In a study carried out for this purpose reported that mothers with hypothyroidism have the risk to deliver babies with low birth weight and to labor prematurely.[24,25]
In some other studies investigating thyroid functions and birth weights analyzed free T4 (FT4) in maternal serum. The study of Shields et al. including 905 pregnant women investigated the relationship between FT4 levels and birth weight at 28 weeks of gestation and found negative correlation. In another similar study, Medici et al. found that high maternal FT4 levels at early weeks of gestation were associated with low birth weight.
In the studies investigating the effects of gestational thyroid functions on fetal and maternal outcomes, thyroid functions were checked in fetal cord blood in addition to maternal serum and their gestational outcomes and association with fetal development were investigated.
Medici et al. showed significant relationship between birth weight and FT4 levels checked in the fetal cord blood of normal healthy pregnant women. Also in this study, no significant relationship was found between fetal weight and FT3 or TSH results checked in cord blood. A positive correlation was found between birth weight and TSH levels in cord blood.
It can be argued in our study that why FT4 and FT3 were not evaluated together with TSH levels in our patients in terms of their association with fetal birth weight. However, as a routine procedure, FT3 and FT4 levels are not checked in our clinic in addition to TSH in the first examination. Yet, in patients found to have TSH levels outside the normal ranges, these tests were carried out for evaluation. Also, not considering heights and weights of mothers and fathers, BMI score of mother at the beginning of pregnancy, dietary habits of mother, smoking and alcohol use habits as the factors affecting fetal birth weight are the weakness of our study. In addition, TSH levels at other periods of pregnancy could be checked in terms of their effects on fetal birth weight; however, when TSH levels were found within normal ranges in the first examination, they were not checked again in our clinic during the other periods of pregnancy. Our study is not a study investigating maternal thyroid levels and poor perinatal outcomes but the first study investigating the relationship between fetal weight and maternal TSH levels within normal ranges as far as we know in the literature.
In conclusion, previous studies investigated and presented the abnormal serum TSH levels and thyroid dysfunctions requiring treatment on fetal birth weight. Our study investigated the effect of serum TSH levels on birth weight in patients with normal TSH values and had no thyroid dysfunction history. We found that TSH levels within normal ranges and at different levels have no effect on fetal birth weight and that a further examination is not required in terms of thyroid functions when TSH level is found within normal ranges at first trimester in terms of affecting fetal weight.
We would like to thank biostatistics specialist Hüseyin Candan who carried out statistical analyses of our study.
- Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010;31:702–55. [PubMed] [CrossRef]
- Haddow JE, McClain MR, Lambert-Messerlian G, Palomaki GE, Canick JA, Cleary-Goldman J, et al.; First and Second Trimester Evaluation of Risk for Fetal Aneuploidy Research Consortium. Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy. J Clin Endocrinol Metab 2008;93:3341–7. [PubMed] [CrossRef]
- Negro R. Significance and management of low TSH in pregnancy. In: Lazarus J, Pirags V, Butz S, editors. The thyroid and reproduction. New York: Georg Thieme Verlag; 2009. p. 84–95.
- Medici M, de Rijke YB, Peeters RP, Visser W, de Muinck Keizer-Schrama SM, Jaddoe VV, et al. Maternal early pregnancy and newborn thyroid hormone parameters: the Generation R study. J Clin Endocrinol Metab 2012;97:646–52. [PubMed] [CrossRef]
- Kothari A, Girling J. Hypothyroidism in pregnancy: prepregnancy thyroid status influences gestational thyroxine requirements. BJOG 2008;115:1704–8.–95. [PubMed] [CrossRef]
- Lazarus JH. Thyroid function in pregnancy. Br Med Bull 2011;97:137–48. [PubMed] [CrossRef]
- Okosieme OE, Lazarus JH. Thyroid dysfunction in pregnancy: optimizing fetal and maternal outcomes. Expert Review of Endocrinology & Metabolism 2010;5:521–9.–95. [CrossRef]
- Luewan S, Chakkabut P, Tongsong T. Outcomes of pregnancy complicated with hyperthyroidism: a cohort study. Arch Gynecol Obstet 2011;283:243–7. [PubMed] [CrossRef]
- Sahu MT, Das V, Mittal S, Agarwal A, Sahu M. Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet 2010;281:215–20. [PubMed] [CrossRef]
- Su PY, Huang K, Hao JH, Xu YQ, Yan SQ, Li T, et al. Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. J Clin Endocrinol Metab 2011;96:3234–41. [PubMed] [CrossRef]
- Shields BM, Knight BA, Hill A, Hattersley AT, Vaidya B. Fetal thyroid hormone level at birth is associated with fetal growth. J Clin Endocrinol Metab 2011;96:E934-8. [PubMed] [CrossRef]
- De Geyter C, Steimann S, Müller B, Kranzlin ME, Meier C. Pattern of thyroid function during early pregnancy in women diagnosed with subclinical hypothyroidism and treated with l-thyroxine is similar to that in euthyroid controls. Thyroid 2009;19:53–9. [PubMed] [CrossRef]
- Chan SY, Vasilopoulou E, Kilby MD. The role of the placenta in thyroid hormone delivery to the fetus. Nat Clin Pract Endocrinol Metab 2009;5:45–54. [PubMed] [CrossRef]
- Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, et al.; American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002;8:457–69. [PubMed] [CrossRef]
- American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 37, August 2002. (Replaces Practice Bulletin Number 32, November 2001). Thyroid disease in pregnancy. Obstet Gynecol 2002;100:387–96. [PubMed]
- Medici M, Timmermans S, Visser W, de Muinck Keizer-Schrama SM, Jaddoe WM, Hofman A, et al. Maternal thyroid hormone parameters during early pregnancy and birth weight: the Generation R Study. J Clin Endocrinol Metab 2013;98:59–66. [PubMed] [CrossRef]
- Vaidya B, Hubalewska-Dydejczyk A, Laurberg P, Negro R, Vermiglio F, Poppe K. Treatment and screening of hypothyroidism in pregnancy: results of a European survey. Eur J Endocrinol 2012;166:49–54. [PubMed] [CrossRef]
- Haddow JE, Knight GJ, Palomaki GE, McClain MR, Pulkkinen AJ. The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen2004;11:170–4. hypothyroidism in pregnancy: results of a European survey. Eur J Endocrinol 2012;166:49–54. [PubMed] [CrossRef]
- Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Role of thyroid hormone during early brain development. Eur J Endocrinol 2004;151 Suppl 3:U25-37. [PubMed] [CrossRef]
- Capelo LP, Beber EH, Huang SA, Zorn TM, Bianco AC, Gouveia CH. Deiodinase-mediated thyroid hormone inactivation minimizes thyroid hormone signaling in the early development of fetal skeleton. Bone 2008;43:921–30. [PubMed] [CrossRef]
- Bassett JH, Williams AJ, Murphy E, Boyde A, Howell PG, Swinhoe R, et al. A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism. Mol Endocrinol 2008;22:501–12. [PubMed] [CrossRef]
- Alvarez-Pedrerol M, Guxens M, Mendez M, Canet Y, Martorell R, Espada M, et al. Iodine levels and thyroid hormones in healthy pregnant women and birth weight of their offspring. Eur J Endocrinol 2009;160:423–9. [PubMed] [CrossRef]
- Vaidya B, Anthony S, Bilous M, Shields B, Drury J, Hutchison S, et al. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 2007;92:203–7. [PubMed] [CrossRef]
- Poppe K, Velkeniers B, Glinoer D. The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab 2008;4:394–405. [PubMed] [CrossRef]
- Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007;92(8 Suppl):S1–47. [PubMed] [CrossRef]
- Bassols J, Prats-Puig A, Soriano-Rodríguez P, García-González MM, Reid J, Martínez-Pascual M, et al. Lower free thyroxin associates with a less favorable metabolic phenotype in healthy pregnant women. J Clin Endocrinol Metab 2011;96:3717–23. [PubMed] [CrossRef]
- Shields BM, Knight BA, Hill A, Hattersley AT, Vaidya B. Fetal thyroid hormone level at birth is associated with fetal growth. J Clin Endocrinol Metab 2011;96:E934–8. [PubMed] [CrossRef]
Comparison of demographic data of the groups with TSH
levels between 0.4 and 2.5 mU/L and between 2.5 and 4.2
TSH düzeyi 0.4–2.5 mU/L aras›nda ve 2.5–4.2 mU/L aras›nda
olan gruplar›n fetal do¤um a¤›rl›klar›n›n kilo gruplar›na göre